Abstract:Background: Glucocorticoid plays an important role in the control of carbohydrate metabolism. Patients with Cushing's syndrome have been reported to have an increased incidence of carbohydrate intolerance due to peripheral insulin resistance and hyperinsulinernia, although the exact incidence and nature of this disorder have remained unclear. Few results have been published about insulin resistance and insulin secretion according to the level of glucose concentration, or about the reversibility of such defects in patients with Cushing's syndrome. Methods: To assess the effect of glucocorticoid on the insulin sensitivity and insulin secretion in Cushing's syndrome, 15 patients with Cushing's syndrome were classified into 3 groups (normal glucose tolerance: NGT, impaired glucose tolerance: lGT, diabetes: DM) according to the degree of glucose tolerance based on the oral glucose tolerance test (DGIT). Insulin modified, frequently sampled, intravenous glucose tolerance test (FSlGT) was performed before and after curative surgery on these patients and on 15 healthy control subjects. Data were evaluated by non-parametric statistical analysis. Results: 1) Amoug the 15 patieuts with Cushiug's syudrome, 3 (20%) were NGT, 4 (27%) IGT, and 8 (53%) DM, based on OGTT. Twenty-four hour urinary free cortisol (UFC) was significantly higher in the DM group. 2) Insulin sensitivity index (SI) of Cushing's syndrome was significantly lower than that of the control group (P=0.0024), but was not significantly different among the three Cushing's syudrome groups of NGT, IGT and DM. 3) Glucose mediated glucose disposal (SG) (Edconfirm this abbreviation; it does not seem to match the definition) of Cushing's syndrome was not significantly different from that of the control group. 4) Insulin secretion (AIRg) of Cushing's syndrome tended to be high, but it was not significantly different from that of control. However, according to the level of glucose concentration there was significant difference in AlRg among the three Cushing's syndrome groups (P=0.003l); AIRg of DM was significantly lower than that of NGT. 5) After surgical treatment, parameters of insulin sensitivity and insulin secretion were normalized in 6 cured patients; 1 with NGT, 1 with IGT, and 4 with DM, preoperatively. Median Sl of all 6 patients was significantly improved up to the normal range postoperatively (P=0.0022). Median AIRg of these 6 patients was balanced around that of normal control postoperatively (P=0.0286). Conclusion: Eighty percent of patients with Cushing's syndrome had abnormality of carbohydrate metabolism. Insulin sensitivity was significantly decreased in Cushing's syndrome. Insulin secretion was significantly higher only in the NGT and lGT groups of Cushing's syndrome. As the hypercortisolemia is exacerbated, insulin secretion is significantly decreased and causes DM, suggesting that glucocorticoid has a direct or indirect toxic effect on the pancreatic beta cell.

Symptomatic changes of metabolic syndrome in subclinical Cushing's syndrome of adrenal incidentaloma and Cushing's syndrome with adrenal adenoma before and after operation

Subclinical Cushing's syndrome in patients with adrenal incidentaloma

Metabolic Syndrome in Subclinical Cushing’s Syndrome of Adrenal Incidentaloma

[Clinical Features and Outcomes of Surgical Versus Conservative Management in Patients with Subclinical Cushing's Syndrome].

The Clinical Analysis of Severe Adrenal Cushing′s Syndrome

The Change of Insulin Sensitivity and Insulin Secretion According to Glucose Metabolism Status in Patients with Cushing's Syndrome

Primary hypothyroidism and postoperative hypothalamus syndrome in a patient after craniopharyngioma surgery

Blood cell and electrolyte change in diagnosis and surgical treatment of Cushing's disease

SAT-370 Clinical Characteristics and Metabolic Features of Patients with Subclinical Cushing's Syndrome and Its Correlation with Cortisol Level

Prognosis of Patients with Subclinical Cushing's Syndrome in Adrenal Incidentaloma

Clinical Investigation on Minimal Invasive Surgery for Cushing Syndrome Caused by Adrenocortical Adenoma: Experience of 121 Cases in a Single Center

[Clinical Characteristics of Primary Aldosteronism with Concurrent Adrenal Cushing's Syndrome].

Adrenal Gland Surgery in the Treatment of Hyperadrenocorticism Curative Effect Appraisal

Study of correlative mitigating factors after the surgery for Cushing's disease

The Diagnosis and Surgical Treatment of Pituitary ACTH- secreting Cushing’s Adenoma

[Metabolic Syndrome in Patients with Adrenocortical Adenoma].

Case Report: Primary Aldosteronism and Subclinical Cushing Syndrome in a 49-Year-old Woman with Hypertension Plus Hypokalaemia.

The Observation to the Change of Blood Sugar Anterior-Posterior Chemotherapy of Patients with Malignant Tumor

Changes in Body Mass Index in Pheochromocytoma Patients Following Adrenalectomy

Transsphenoidal surgery on pituitary Cushing's disease: efficiency evaluation

Malignant adrenal tumors (report of 50 cases)